Clinical trial
The Role of Adjuvant Cross Linking in the Management of Infective Keratitis - an OCT Based Assessment Study
NCT06967376 is registered in ClinicalTrials.gov with Research Institute of Ophthalmology, Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Adjuvant Cross Linking in the Management of Infective Keratitis - an OCT Based Assessment Study
- Lead sponsor
- Research Institute of Ophthalmology, Egypt
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 21, 2018
- Completion date
- February 3, 2022
- Enrollment
- 40 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
infective keratitis